The Board of Directors of BONESUPPORT HOLDING AB (“BONESUPPORT”) has today resolved to utilize one of the two authorizations to acquire own ordinary shares granted by the Annual General Meeting on 12 May 2026. The Board of Directors has resolved to acquire a maximum of 373,320 ordinary shares for a total amount of maximum SEK 100 million for the purpose of ensuring BONESUPPORT’s obligations arising from the long-term share savings program LTI 2026 as resolved by the Annual General Meeting on 12 May 2026.
The acquisition of shares will be carried out in accordance with the Market Abuse Regulation (EU) 596/2014 ("MAR") and the European Commission's Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). The acquisition of shares will be managed by DNB Carnegie Investment Bank AB that will make its own trading decisions regarding the timing of the acquisitions independently of BONESUPPORT.
The following terms and conditions apply to the acquisitions of shares:
As per 8 June 2026, the total number of shares in BONESUPPORT HOLDING AB is 66,764,350, of which 65,859,195 are ordinary shares and 905,155 are Series C shares. BONESUPPORT HOLDING AB holds no ordinary shares and 905,155 Series C shares as per the same date.